112
Views
3
CrossRef citations to date
0
Altmetric
Letters

Successful treatment of skin fistulas in systemic sclerosis patients with the combination of topical negative pressure therapy and split-thickness skin grafting

, , , , , , , & show all
Pages 374-376 | Received 30 Jan 2013, Accepted 13 Mar 2013, Published online: 05 Mar 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Hisashi Kanemaru, Ikko Kajihara, Kotaro Yamanaka, Toshikatsu Igata, Takamitsu Makino, Shinichi Masuguchi, Satoshi Fukushima, Masatoshi Jinnin & Hironobu Ihn. (2015) Platelet-rich plasma therapy is effective for the treatment of refractory skin ulcers in patients with systemic sclerosis. Modern Rheumatology 25:4, pages 660-661.
Read now

Articles from other publishers (2)

Yoshihide Asano, Masatoshi Jinnin, Yasushi Kawaguchi, Masataka Kuwana, Daisuke Goto, Shinichi Sato, Kazuhiko Takehara, Masaru Hatano, Manabu Fujimoto, Naoki Mugii & Hironobu Ihn. (2018) Diagnostic criteria, severity classification and guidelines of systemic sclerosis. The Journal of Dermatology 45:6, pages 633-691.
Crossref
Kayo Nakamura, Masatoshi Jinnin, Miho Harada, Hideo Kudo, Wakana Nakayama, Kuniko Inoue, Aki Ogata, Ikko Kajihara, Satoshi Fukushima & Hironobu Ihn. (2016) Altered expression of CD63 and exosomes in scleroderma dermal fibroblasts. Journal of Dermatological Science 84:1, pages 30-39.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.